Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy

The effects of inhibition of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways and chemotherapeutic drugs on cell cycle progression and drug sensitivity were examined in cytokine-dependent FL5.12 hematopoietic cells. We examined their effects, as these cells resemble normal hematopoietic precurso...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Abrams, Stephen L., Steelman, Linda S., Shelton, John G., Chappell, William, Bäsecke, Jörg, Stivala, Franca, Donia, Marco, Nicoletti, Ferdinando, Libra, Massimo, Martelli, Alberto M., McCubrey, James A.
Format: Artigo
Langue:Inglês
Publié: Landes Bioscience 2010
Sujets:
Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3781183/
https://ncbi.nlm.nih.gov/pubmed/20436269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cc.9.9.11544
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires